Published online before print December 21, 2005, 10.1148/radiol.2382041053
Dutch Iliac Stent Trial: Long-term Results in Patients Randomized for Primary or Selective Stent Placement1
Willemijn M. Klein, MD, PhD,
Yolanda van der Graaf, MD, PhD,
Jan Seegers, MD, PhD,
Johannes H. Spithoven, MD,
Erik Buskens, MD, PhD,
Jeff G. van Baal, MD, PhD,
Jaap Buth, MD, PhD,
Frans L. Moll, MD, PhD2,
Tim T. C. Overtoom, MD,
Marc R. H. M. van Sambeek, MD, PhD and
Willem P. T. M. Mali, MD, PhD
1 From the Department of Radiology (W.M.K., W.P.T.M.M.) and Julius Center of Health Sciences and Primary Care (Y.v.d.G., E.B.), University Medical Center Utrecht, Room E.01.132, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands; Departments of Vascular Surgery (J.S.) and Interventional Radiology (J.H.S.), Slingeland Hospital, Doetinchem, the Netherlands; Department of Vascular Surgery, Twenteborg Hospital, Almelo, the Netherlands (J.G.v.B.); Department of Vascular Surgery, Catharina Hospital, Eindhoven, the Netherlands (J.B.); Departments of Vascular Surgery (F.L.M.) and Interventional Radiology (T.T.C.O.), St Antonius Hospital, Nieuwegein, the Netherlands; and Department of Vascular Surgery, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands (M.R.H.M.v.S.). A complete list of centers that participated in the Dutch Iliac Stent Trial Study Group is included in the Acknowledgments. Received June 14, 2004; revision requested August 25; final revision received February 25, 2005; accepted March 18; final version accepted May 3. Supported by Cordis.
Address correspondence to W.P.T.M.M. (e-mail: W.Mali{at}azu.nl).

View larger version (25K):
[in a new window]
|
Figure 1: Kaplan-Meier survival curves for symptomatic success. Solid line signifies primary stent placement (101 of 143 patients); and dotted line, PTA with selective stent placement (80 of 134 patients).
|
|

View larger version (25K):
[in a new window]
|
Figure 2: Kaplan-Meier survival curves for hemodynamic success measured with ABI. Solid line signifies primary stent placement (81 of 136 events); and dotted line, PTA with selective stent placement (68 of 126 events).
|
|

View larger version (24K):
[in a new window]
|
Figure 3: Kaplan-Meier survival curves for iliac patency measured with duplex US. Solid line signifies primary stent placement (33 of 139 patients); and dotted line, PTA with selective stent placement (38 of 130 patients).
|
|

View larger version (15K):
[in a new window]
|
Figure 4a: Graphs show RAND 36-Item Health Survey scores for (a) physical functioning and (b) bodily pain in two treatment groups of the DIST study and in age-matched controls. Solid line signifies group with primary stent placement; dotted line, group with PTA and selective stent placement; and dashed and dotted line, age-matched controls. At long term, scores of patients treated with selective stent placement were not different from data in age-matched controls, whereas patients with primary stent placement had lower scores.
|
|

View larger version (14K):
[in a new window]
|
Figure 4b: Graphs show RAND 36-Item Health Survey scores for (a) physical functioning and (b) bodily pain in two treatment groups of the DIST study and in age-matched controls. Solid line signifies group with primary stent placement; dotted line, group with PTA and selective stent placement; and dashed and dotted line, age-matched controls. At long term, scores of patients treated with selective stent placement were not different from data in age-matched controls, whereas patients with primary stent placement had lower scores.
|
|
Copyright © 2005 by the Radiological Society of North America.